Arkolith/Insider Trading/NLTX/Form 4

Walkey Carl

Senior Vice PresidentNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed Apr 22, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2021Sell(S)2K$11.98$22K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-027971) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML